PALI – palisade bio, inc. (US:NASDAQ)
Stock Stats
News
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules [Yahoo! Finance]
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
Palisade Bio, Inc. (NASDAQ: PALI) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $22.50 price target on the stock.
Palisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS) [Yahoo! Finance]
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)
Form 8-K PALISADE BIO, INC. For: May 03
Form 8-K PALISADE BIO, INC. For: Apr 10
Form S-3 PALISADE BIO, INC.
Form S-8 PALISADE BIO, INC.
Form 8-K PALISADE BIO, INC. For: Mar 27
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.